Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Cesano

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Cytometry. Part B, Clinical Cytometry|October 10, 2013
Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDSSteven M Kornblau, Aileen C Cohen, David Soper, et al.
Journal for Immunotherapy of Cancer|March 17, 2019
Correction to: A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activityPatrick Danaher, Sarah Warren, Su Fey Ong, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2013
Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDSSteven M Kornblau, Aileen C Cohen, David Soper, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Development of Gene Expression-Based Biomarkers on the nCounter<sup>®</sup> Platform for Immuno-Oncology ApplicationsSarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, et al.
Pharmacotherapy|September 28, 2007
Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignanciesParnian Zia-Amirhosseini, David D Hurd, Margaret Salfi, et al.
Plos One|October 22, 2011
Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cellsAdam L Palazzo, Erik Evensen, Ying-Wen Huang, et al.
Molecular Immunology|July 4, 2006
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximabJosette Carnahan, Rhona Stein, Zhengxing Qu, et al.
Leukemia Research|April 24, 2012
Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AMLDavid B Rosen, James A Cordeiro, Aileen Cohen, et al.
American Journal of Clinical and Experimental Immunology|July 26, 2013
Inter-donor variation in cell subset specific immune signaling responses in healthy individualsDiane M Longo, Brent Louie, Ena Wang, et al.
Oncotarget|November 17, 2016
Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case reportMiguel H Bronchud, Francesc Tresserra, Wenjie Xu, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Cytometry. Part B, Clinical Cytometry|October 10, 2013
Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDSSteven M Kornblau, Aileen C Cohen, David Soper, et al.
Journal for Immunotherapy of Cancer|March 17, 2019
Correction to: A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activityPatrick Danaher, Sarah Warren, Su Fey Ong, et al.
Cytometry. Part B, Clinical Cytometry|August 21, 2013
Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDSSteven M Kornblau, Aileen C Cohen, David Soper, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Development of Gene Expression-Based Biomarkers on the nCounter<sup>®</sup> Platform for Immuno-Oncology ApplicationsSarah Warren, Patrick Danaher, Afshin Mashadi-Hossein, et al.
Pharmacotherapy|September 28, 2007
Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignanciesParnian Zia-Amirhosseini, David D Hurd, Margaret Salfi, et al.
Plos One|October 22, 2011
Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cellsAdam L Palazzo, Erik Evensen, Ying-Wen Huang, et al.
Molecular Immunology|July 4, 2006
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximabJosette Carnahan, Rhona Stein, Zhengxing Qu, et al.
Leukemia Research|April 24, 2012
Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AMLDavid B Rosen, James A Cordeiro, Aileen Cohen, et al.
American Journal of Clinical and Experimental Immunology|July 26, 2013
Inter-donor variation in cell subset specific immune signaling responses in healthy individualsDiane M Longo, Brent Louie, Ena Wang, et al.
Oncotarget|November 17, 2016
Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case reportMiguel H Bronchud, Francesc Tresserra, Wenjie Xu, et al.
Pageof 9